Execs On The Move, September 2013
Executive Summary
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
| Table |
|---|
Advertisement
Topics
- Industries
- BioPharmaceutical
- Medical Device
Related Companies
- Promentis Pharmaceuticals Inc.
- TetraLogic Pharmaceuticals Corp.
- RF Surgical Systems Inc.
- SciClone Pharmaceuticals Inc.
- Clarus Therapeutics Inc.
- Endo International PLC
- BioPorto Diagnostics AS
- Aqua Pharmaceuticals LLC
- AtriCure Inc.
- Align Technology Inc.
- Quest Diagnostics Inc.
- Ironwood Pharmaceuticals Inc.
- Hyperion Therapeutics Inc.
- ARUP Laboratories
- Sage Therapeutics Inc.
- KemPharm Inc.
- Sage Therapeutics Inc.
- Sage Therapeutics Inc.
- OrthoSensor Inc.
- Gradalis Inc.
- Saladax Biomedical Inc.
- OrthoSensor Inc.
- TetraLogic Pharmaceuticals Corp.
- MolecularMD Corp.
- Opko Health Inc.
- Bioventus Inc.
- Visterra Inc.
- CytomX Therapeutics Inc.
- Becton Dickinson & Co.
- KalVista Pharmaceuticals Inc.
- Biolase Inc.
- TetraLogic Pharmaceuticals Corp.
- Clarus Therapeutics Inc.
- MediStem Inc.
- NovaSom Inc.
- Teleflex Inc.
- Align Technology Inc.
- DJO Global Inc.
- AMAG Pharmaceuticals Inc.
- SpineVision Inc.
- Progenics Pharmaceuticals Inc.
- Vivus Inc.
- Aerie Pharmaceuticals Inc.
- Aveo Pharmaceuticals Inc.
- Merz North America Inc.
- Dynavax Technologies Corp.
- IMRIS Inc.
- Epizyme Inc.
- BioSante Pharmaceuticals Inc.
- Taro Pharmaceutical Industries Ltd.
- Aveo Pharmaceuticals Inc.
- Cellectar Biosciences Inc.
- Lantheus Holdings Inc.
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
IV004101
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
IV004101
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.